Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07599852 · ClinicalTrials.gov registry record · NA
MEDBRIDGE-Guided NCM/CHW Post-Discharge Support for High-Risk T2D Patients
A NA study, sponsored by University of Alabama at Birmingham.
- Not yet
- Registry status
- NA
- Development phase
- 45
- Enrollment target
NCT07599852 is a NA study that has not yet begun recruiting, run by University of Alabama at Birmingham. The registered enrollment target is 45 participants.
The verdict
NCT07599852, a NA study, has not yet begun recruiting, sponsored by University of Alabama at Birmingham.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 45 participants
- Enrollment target
Study Summary
This study tests whether a support program led by a nurse case manager and community health worker can help patients with type 2 diabetes manage their medications after leaving the hospital. Many patients with diabetes take multiple medications, and changes to these medications during hospital stays can cause confusion and lead to missed doses or incorrect use. This is especially common in communities with limited access to healthcare. The study uses a computer-based tool called MEDBRIDGE (MEDication BRIDGE) to identify patients who may be at higher risk for problems after discharge, such as worsening blood sugar control or return visits to the emergency department. Patients identified as high-risk will receive 3 months of support from a nurse case manager and community health worker team, who will help with medication questions, coordinate with their doctor, and provide follow-up check-ins. The main goal is to find out whether this type of support program is practical to deliver and acceptable to patients. The study will also track changes in blood sugar levels and emergency department visits. Forty-five patients will be enrolled over 6 months at the University of Alabama at Birmingham and Cooper Green Mercy Health Services in Jefferson County, Alabama.
Interventions
- BEHAVIORAL MEDBRIDGE-Guided NCM/CHW Post-Discharge Support Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2029-05-01 |
| Est. Completion | 2031-04-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07599852
The ClinicalTrials.gov registry entry for NCT07599852 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which MEDBRIDGE-Guided NCM/CHW Post-Discharge Support Intervention is the first listed.
NCT07599852 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07599852 about?
NCT07599852 is a clinical study titled "MEDBRIDGE-Guided NCM/CHW Post-Discharge Support for High-Risk T2D Patients". This study tests whether a support program led by a nurse case manager and community health worker can help patients with type 2 diabetes manage their medications after leaving the hospital. Many patients with diabetes take multiple medications, and changes to these medications during hospital stays...
What is the current status of trial NCT07599852?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 45 participants. The study started on 2029-05-01. Estimated completion is 2031-04-30.
What interventions are being tested in trial NCT07599852?
The interventions under investigation include: MEDBRIDGE-Guided NCM/CHW Post-Discharge Support Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT07599852?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.